Menu
Live News EQUITY L impact

Polaryx Therapeutics Files SEC Form

Polaryx Therapeutics submits filing to SEC, disclosure pending. Minor update for shareholders.

PLXR

Filed: 2026-05-28 AccNo: 0001213900-26-062322 Size: 7 KB